Vytrus Biotech SA
MAD:VYT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vytrus Biotech SA
MAD:VYT
|
ES |
|
Aksa Akrilik Kimya Sanayii AS
IST:AKSA.E
|
TR |
|
Mishtann Foods Ltd
BSE:539594
|
IN |
|
J
|
John Menzies PLC
XBER:B3N
|
UK |
|
Zecotek Photonics Inc
OTC:ZMSPF
|
CA |
Income Statement
Earnings Waterfall
Vytrus Biotech SA
Income Statement
Vytrus Biotech SA
| Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
4
N/A
|
4
-2%
|
4
+4%
|
4
+15%
|
5
+18%
|
7
+37%
|
|
| Gross Profit | |||||||
| Cost of Revenue |
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
0
|
|
| Gross Profit |
3
N/A
|
3
0%
|
3
+3%
|
4
+36%
|
4
-2%
|
7
+77%
|
|
| Operating Income | |||||||
| Operating Expenses |
(2)
|
(3)
|
(3)
|
(4)
|
(3)
|
(5)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
|
| Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
(1)
|
0
|
(2)
|
|
| Operating Income |
1
N/A
|
1
-20%
|
0
-15%
|
1
+50%
|
1
+56%
|
2
+110%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Pre-Tax Income |
0
N/A
|
0
-20%
|
0
-14%
|
1
+82%
|
1
+61%
|
2
+127%
|
|
| Net Income | |||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Income from Continuing Operations |
1
|
1
|
1
|
1
|
1
|
2
|
|
| Net Income (Common) |
1
N/A
|
1
+4%
|
1
-13%
|
1
+29%
|
1
+46%
|
2
+91%
|
|
| EPS (Diluted) |
0.09
N/A
|
0.09
N/A
|
0.08
-11%
|
0.1
+25%
|
0.14
+40%
|
0.26
+86%
|
|